» Articles » PMID: 15555220

Expression Levels of Protein Kinase C-alpha in Non-small-cell Lung Cancer

Overview
Publisher Elsevier
Date 2004 Nov 24
PMID 15555220
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Current treatments of non-small-cell lung cancer (NSCLC) are inadequate and new therapies are being developed that target specific cellular signaling proteins associated with tumor growth. One potential target is protein kinase C (PKC)-alpha, a signaling molecule with an important role in cell regulation and proliferation. The present study examines the expression levels of PKC-alpha in NSCLC to better understand the distribution of PKC-alpha in NSCLC. We analyzed tumor specimens from an independent tumor tissue bank to determine PKC-alpha protein and messenger RNA gene expression in NSCLC. In addition, we used publicly available gene expression array data to further understand PKC-a-associated gene expression profiles in NSCLC. We found that PKC-alpha is highly expressed in < or = 20% of patients with NSCLC. We also found that PKC-alpha was preferentially expressed in adenocarcinoma compared with squamous cell carcinoma of the lung.

Citing Articles

Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer.

Kawano T, Inokuchi J, Eto M, Murata M, Kang J Cancers (Basel). 2022; 14(21).

PMID: 36358843 PMC: 9658272. DOI: 10.3390/cancers14215425.


Protein Kinase C as a Therapeutic Target in Non-Small Cell Lung Cancer.

Sadeghi M, Salama M, Hannun Y Int J Mol Sci. 2021; 22(11).

PMID: 34073823 PMC: 8197251. DOI: 10.3390/ijms22115527.


Knockdown of circPRKCA Restrained Cell Growth, Migration, and Invasion of NSCLC Cells Both in vitro and in vivo via Regulating miR-330-5p/PDK1/AKT Pathway.

Bai L, Peng X, Sun R Cancer Manag Res. 2020; 12:9125-9137.

PMID: 33061606 PMC: 7524182. DOI: 10.2147/CMAR.S258370.


HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma.

Jiang H, Fu Q, Song X, Ge C, Li R, Li Z Oncol Lett. 2019; 18(5):4936-4946.

PMID: 31612005 PMC: 6781745. DOI: 10.3892/ol.2019.10812.


PKCα is required for Akt-mTORC1 activation in non-small cell lung carcinoma (NSCLC) with EGFR mutation.

Salama M, Liu M, Clarke C, Espaillat M, Haley J, Jin T Oncogene. 2019; 38(48):7311-7328.

PMID: 31420605 PMC: 6883150. DOI: 10.1038/s41388-019-0950-z.